急性肾损伤的生物标志物。
Biomarkers in Acute Kidney Injury.
机构信息
Division of Nephrology, Faculty of Medicine, Chulalongkorn University, 10th Floor, Bhumisiri mangkhalanusorn Building, Ratchadamri Road, Pathum Wan, Bangkok 10330, Thailand; Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, 1873 Rama IV Road, Pathum Wan, Bangkok 10330, Thailand.
Department of Critical Care Medicine, Center for Critical Care Nephrology, The CRISMA Center, University of Pittsburgh School of Medicine, 3347 Forbes Avenue, Suite 220, Pittsburgh, PA 15213, USA.
出版信息
Crit Care Clin. 2021 Apr;37(2):385-398. doi: 10.1016/j.ccc.2020.11.012.
Biomarkers have become a pillar of precision medicine in acute kidney injury (AKI). Traditional markers for diagnosis of AKI are insensitive and insufficient to provide comprehensive information for prognostication. Several emerging biomarkers have shown promising results in large-scale clinical studies. These novel markers likely will be beneficial for personalized AKI prevention and treatment.
生物标志物已成为急性肾损伤（AKI）精准医学的重要支柱。传统的 AKI 诊断标志物不敏感且不足以提供全面的预后信息。一些新兴的生物标志物在大规模临床研究中显示出了有前景的结果。这些新型标志物可能有助于 AKI 的个体化预防和治疗。
Zotero 插件